HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES

Zacks Education
Visit Zacks' Education section for investing guides and other free resources to make you a better investor.
Quote:
Login
Search:

Commentary BETA - Give us your feedback
Tale of the Tape

JNJ Proves a Safe Investment

By: Aditi Samajpati
October 14, 2008 | Comments: 0
Recommended this article (0)
JNJ
Print    Share

Johnson & Johnson (JNJ - Analyst Report) reported a 30% rise in quarterly profit to beat analyst estimates, helped by a sharp increase in international sales. In the third quarter, net income was $3.31 billion, or $1.17 a share. The drugmaker also tried to assure investors by boosting its 2008 outlook and saying its financial position was healthy despite the ongoing credit crisis.

Johnson & Johnson claimed that the global economic downturn, including credit default swaps and bank failures, will not hurt its sales. For the full year, the New Brunswick, New Jersey-based company now sees earnings of $4.50 to $4.53 a share, up from its previous guidance of $4.45 to $4.50 a share.

While revenue generated from prescription drugs were flat due to generic pressure on schizophrenia drug Risperdal, the consumer products unit that makes Zyrtec allergy pills, Listerine mouthwash and diabetes test-strips, offset the effect. Johnson & Johnson, which is now seen as a safe haven for investors in a turbulent market, gained nearly 3% to trade at $64.14 in the afternoon session.


Email

Print

Share

RSS

Rate Pos

Rate Neg

Comment
Read/Post Comments (0) | Recommended this article (0)
 Posting Comment...
There was a problem posting this this comment. Please try back later.
[CLICK TO CLOSE X]
Comments (Limit 1000 Characters - Used: 0)
Display Name: Email Address:  
 Loading Comments...
Be the first to comment on this article!

More Zacks Resources

Market Summary Jul 04, 2009 09:17 am ET
DJIA 8280.74  -223.32 -2.63%
NASD 1796.52  -49.20 -2.67%
S&P 500 896.42  -26.91 -2.91%
Sponsored Links
Commentary Beta
GIVE US YOUR FEEDBACK